Forward Pharma Appoints Claus Bo Svendsen as Chief Executive Officer and Plans to Reorganize to Reduce Burn Rate Following the Settlement and License Agreement with Biogen
March 01, 2017 09:15 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, March 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or the “Company”) today announced that its Board of Directors has appointed Claus Bo Svendsen, M.D.,...
Forward Pharma Received US$ 1.25bn pursuant to Settlement and License Agreement with Biogen
February 09, 2017 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”) today announced that it has received a non-refundable cash fee of US$ 1.25 billion in...
Forward Pharma Announces Results of Extraordinary General Meeting
February 01, 2017 09:15 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”) today announced that, at an extraordinary general meeting of its shareholders held on...
Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen
January 17, 2017 11:01 ET
|
Forward Pharma A/S
Biogen will pay Forward a non-refundable cash fee of $1.25 billionForward may be eligible to receive royalties of 10% of net sales of Tecfidera beginning in 2021, and of 20% of net sales beginning in...
Forward Pharma Reports Third Quarter 2016 Financial and Operational Results
November 29, 2016 16:15 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the third quarter ended September...
Forward Pharma CFO to Participate in the Credit Suisse Annual Healthcare Conference in November
November 02, 2016 08:00 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate)...
Forward Pharma CFO to Participate in Three Investor Conferences in September
September 06, 2016 08:00 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl...
Forward Pharma Reports Second Quarter 2016 Financial and Operational Results
September 01, 2016 08:00 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the second quarter ended June 30,...
Forward Pharma CFO to Participate in Two Investor Conferences in June
June 06, 2016 16:15 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, June 06, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl...
Forward Pharma Reports First Quarter 2016 Financial and Operational Results
June 02, 2016 16:15 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, June 02, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the first quarter ended March 31,...